PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Tor Vergata University Hospital, Rome, Italy.\', \'Department of Experimental Medicine, University of Tor Vergata, Rome, Italy. Electronic address: massimo.pieri@uniroma2.it.\', \'Department of Experimental Medicine, University of Tor Vergata, Rome, Italy.\', \'Tor Vergata University Hospital, Rome, Italy; Department of System Medicine, University of Tor Vergata, Rome, Italy.\', \'Tor Vergata University Hospital, Rome, Italy; Department of Experimental Medicine, University of Tor Vergata, Rome, Italy; IFCC Emerging Technologies Division, Milan, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1567-5769(20)33797-810.1016/j.intimp.2020.107330
?:doi
?:hasPublicationType
?:journal
  • International immunopharmacology
is ?:pmid of
?:pmid
?:pmid
  • 33412393
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.051
?:rankingScore_hIndex
  • 94
is ?:relation_isRelatedTo_publication of
?:title
  • Evaluation of a new simultaneous anti-SARS-CoV-2 IgA, IgM and IgG screening automated assay based on native inactivated virus.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all